Home>>Peptides>>Kinetensin (human) (trifluoroacetate salt)

Kinetensin (human) (trifluoroacetate salt) (Synonyms: IARRHPYFL, Ile-Ala-Arg-Arg-His-Pro-Tyr-Phe-Leu)

Catalog No.GC48340

Products are for research use only. Not for human use. We do not sell to patients.

Kinetensin (human) (trifluoroacetate salt) Chemical Structure

Size Price Stock Qty
1mg
$43.00
In stock
5mg
$194.00
In stock
10mg
$342.00
In stock
25mg
$750.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com


Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description of Kinetensin (human) (trifluoroacetate salt)

Kinetensin is a nonapeptide that has been found in pepsin-treated human plasma.1 It binds to neurotensin receptors in HT-29 cells and mouse brain (Kis = 1,396 and 149.6 nM, respectively, in radioligand binding assays) but does not induce the accumulation of intracellular calcium in HT-29 cells (EC50 = >10,000 nM).2 It induces histamine release in isolated rat peritoneal mast cells with an EC50 value of approximately 10 µM.3 Intradermal administration of kinetensin induces vascular permeability in rats.

1.Mogard, M.H., Kobayashi, R., Chen, C.F., et al.The amino acid sequence of kinetensin, a novel peptide isolated from pepsin-treated human plasma: Homology with human serum albumin, neurotensin and angiotensinBiochem. Biophys. Res. Commun.136(3)983-988(1986) 2.Akunne, H.C., Demattos, S.B., Whetzel, S.Z., et al.Agonist properties of a stable hexapeptide analog of neurotensin, NαMeArg-Lys-Pro-Trp-tLeu-Leu (NT1)Biochem. Pharmacol.49(8)1147-1154(1995) 3.Sydbom, A., Ware, J., and Mogard, M.H.Stimulation of histamine release by the peptide kinetensinAgents Actions27(1-2)68-71(1989)

Chemical Properties of Kinetensin (human) (trifluoroacetate salt)

Cas No. SDF
Synonyms IARRHPYFL, Ile-Ala-Arg-Arg-His-Pro-Tyr-Phe-Leu
Canonical SMILES CC[C@H](C)[C@H](N)C(N[C@@H](C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC1=CN=CN1)C(N2[C@H](C(N[C@@H](CC3=CC=C(O)C=C3)C(N[C@@H](CC4=CC=CC=C4)C(N[C@H](C(O)=O)CC(C)C)=O)=O)=O)CCC2)=O)=O)=O)=O)=O.OC(C(F)(F)F)=O
Formula C56H85N17O11•XCF3COOH M.Wt 1172.4
Solubility Water: 2 mg/ml Storage -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table of Kinetensin (human) (trifluoroacetate salt)

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 0.853 mL 4.2648 mL 8.5295 mL
5 mM 0.1706 mL 0.853 mL 1.7059 mL
10 mM 0.0853 mL 0.4265 mL 0.853 mL
  • Molarity Calculator

  • Dilution Calculator

  • Molecular Weight Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
**When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / CoA (available online).

Calculate

In vivo Formulation Calculator (Clear solution) of Kinetensin (human) (trifluoroacetate salt)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Product Documents

Quality Control & SDS

View current batch:

Reviews

Review for Kinetensin (human) (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Kinetensin (human) (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.